SUVEN PHARMACEUTICALS
Back to Cashflow Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹3.32 Cr | ₹-40 Cr | ₹-242 Cr | ₹-156 Cr | ₹-76 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUVEN PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹3.32 Cr |
| Mar2024 | ₹-40 Cr |
| Mar2023 | ₹-242 Cr |
| Mar2022 | ₹-156 Cr |
| Mar2021 | ₹-76 Cr |
How is Cash Flow from Financing Activities of SUVEN PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.32 Cr | Positive | |
| Mar2024 | ₹-40 Cr | Negative | |
| Mar2023 | ₹-242 Cr | Negative | |
| Mar2022 | ₹-156 Cr | Negative | |
| Mar2021 | ₹-76 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹20,568.6 Cr | 1% | -4.4% | -54.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 2% | 2.4% | 11.2% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | 1% |
-4.4% |
-54.6% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses